“By achieving ISO accreditation, Pantec Biosolutions can now offer full quality assurance in terms of product development and production of laser-based medical devices”, stated Dr. Christof Boehler, CEO of Pantec Biosolutions. “We are currently aiming to further develop our drug delivery platform by implementing only the highest standards of international quality and extending these standards to all aspects of our business.”
About Pantec Biosolutions and P.L.E.A.S.E.® Pantec Biosolutions is a private drug delivery company specialised in using laser microporation technology to deliver large molecular weight drugs into the epidermis for local or systemic uptake. Its proprietary P.L.E.A.S.E.® (Painless Laser Epidermal System) platform enables efficient, needle-free and painless administration of biopharmaceutical drugs, in varying and individualised dosages, through partnered patch technology. The technology is currently in clinical trials for the delivery of IVF hormone therapy, a market with an estimated value of US$1.5 – 2 billion.
Pantec Biosolutions’ P.L.E.A.S.E.® platform is available both for the development of the Company’s own pipeline and for penetration into new markets through strategic partnerships. Pantec Biosolutions is based in Ruggell, Liechtenstein.
Further Information: Dr. Christof Boehler CEO Pantec Biosolutions AG t: +423 377 7800 e: christof.boehler@pantec-biosolutions.com
Douglas Pretsell Account Director College Hill Life Sciences t: +49 (0)89 57 00 18 06 e: douglas.pretsell@collegehill.com
